⚠️

Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.

Tdap (Boostrix)2006

Tdap (Boostrix) in 2006

1,224 adverse event reports (+999% vs 2005)(first full year of widespread reporting)

1,224

Reports

Deaths

Hospitalizations

437

ER Visits

Disabilities

← 2005 (107 reports)2007 (2,555 reports) →

2006 Reporting Summary

In 2006, 1,224 adverse event reports were filed for Tdap (Boostrix) in VAERS. This represents 2.3% of all 52,846 reports for this vaccine.

Of these reports, 2 mentioned death, 62 involved hospitalization, 437 required ER visits, and 11 reported disability.

Compared to the average of 2,394 reports per year for this vaccine, 2006 was below average (-49%).

💡 What This Means

Year-over-year change: The large change from 2005 likely reflects a ramp-up in vaccination (e.g., new vaccine rollout or expanded eligibility) rather than a change in per-dose risk.

All Years for Tdap (Boostrix)

Year	Reports	Deaths	Hosp.
2025	2,379	4	55
2024	2,326	4	55
2023	2,160	4	37
2022	1,790	3	36
2021	1,680	4	46
2020	1,543	4	50
2019	2,475	5	101
2018	2,393	10	81
2017	2,825	1	98
2016	3,118	4	101
2015	3,149	3	112
2014	2,494	4	115
2013	2,478	9	107
2012	3,271	8	132
2011	3,370	6	151
2010	3,295	7	132
2009	2,732	7	106
2008	2,917	9	118
2007	2,555	5	113
2006 ← current	1,224	2	62
2005	107	1	7

Understanding Yearly Data

•Spikes may reflect awareness: Years with unusual activity (e.g., pandemic) often see increased reporting.

•Dose volume matters: More vaccinations given in a year naturally leads to more reports.

•Reporting lag: Some events are reported months after they occur, so recent years may be incomplete.

Quick Facts

Reports:1,224

Deaths:2

Hospitalizations:62

% of Total:2.3%

Rank (by vol.):#20 of 21 years

Avg/year:2,394

Tdap (Boostrix) Overview ← 2005 Reports 2007 Reports →35 Years of Reporting Compare Vaccines

Data Source

This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.

2006 Reporting Summary

In 2006, 1,224 adverse event reports were filed for Tdap (Boostrix) in VAERS. This represents 2.3% of all 52,846 reports for this vaccine.

Of these reports, 2 mentioned death, 62 involved hospitalization, 437 required ER visits, and 11 reported disability.

Compared to the average of 2,394 reports per year for this vaccine, 2006 was below average (-49%).